Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Intangibles (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Intangibles for 3 consecutive years, with $716806.0 as the latest value for Q4 2025.

  • Quarterly Intangibles fell 7.53% to $716806.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $716806.0 through Dec 2025, down 7.53% year-over-year, with the annual reading at $716806.0 for FY2025, 7.53% down from the prior year.
  • Intangibles for Q4 2025 was $716806.0 at bioAffinity Technologies, down from $731389.0 in the prior quarter.
  • The five-year high for Intangibles was $2.3 million in Q3 2024, with the low at $716806.0 in Q4 2025.
  • Average Intangibles over 3 years is $1.2 million, with a median of $789722.5 recorded in 2024.
  • The sharpest move saw Intangibles rose 12.92% in 2024, then tumbled 67.56% in 2025.
  • Over 3 years, Intangibles stood at $833472.0 in 2023, then fell by 7.0% to $775139.0 in 2024, then fell by 7.53% to $716806.0 in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $716806.0, $731389.0, and $745972.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.